Pramipexole Upregulates Dopamine Receptor D2 and D3 Expression in Rat Striatum

Pramipexole Upregulates Dopamine Receptor D2 and D3 Expression in Rat Striatum

Randomized clinical trials have shown that pramipexole has an antidepressant effect in patients with Parkinson’s disease. We investigated the comparative efficacy of pramipexole toward dopamine receptor D2 and D3 expression in rat brain. Groups of rats were treated subacutely with pramipexole (1 mg/...

Full description

Bibliographic Details
Main Authors:	Naohito Tokunaga, Mohammed Emamussalehin Choudhury, Noriko Nishikawa, Masahiro Nagai, Tomoaki Tujii, Hirotaka Iwaki, Mika Kaneta, Masahiro Nomoto
Format:	Article
Language:	English
Published:	Elsevier 2012-01-01
Series:	Journal of Pharmacological Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861319304529

Similar Items

Zonisamide Increases Dopamine Turnover in the Striatum of Mice and Common Marmosets Treated With MPTP
by: Hayato Yabe, et al.
Published: (2009-01-01)

Zonisamide Attenuates MPTP Neurotoxicity in Marmosets
by: Mohammed Emamussalehin Choudhury, et al.
Published: (2010-01-01)

Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease
by: Rina Ando, et al.
Published: (2018-04-01)

Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients
by: Angela Deutschländer, et al.
Published: (2016-01-01)

Enhanced taste recognition following subacute treatment with the dopamine D2/D3 receptor agonist pramipexole in healthy volunteers
by: Kaltenboeck, A, et al.
Published: (2022)

Pramipexole, a dopamine D3/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in mice
by: Carlos Pereira Martins, et al.
Published: (2022-01-01)

Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease
by: S N Illarioshkin
Published: (2012-06-01)

Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole
by: M. R. Nodel
Published: (2011-12-01)

Dopamine D1-D2 receptor heteromer expression in key brain regions of rat and higher species: Upregulation in rat striatum after cocaine administration
by: Ahmed Hasbi, et al.
Published: (2020-09-01)

Heterogeneity of dopamine release in the primate striatum
by: Cragg, S, et al.
Published: (2002)

Acetylcholine waves and dopamine release in the striatum
by: Lior Matityahu, et al.
Published: (2023-10-01)

The dopamine neuron synaptic map in the striatum
by: Nao Chuhma, et al.
Published: (2023-03-01)

Cerebrovascular integrity affects gradients of aging-related dopamine D1 differences in the striatum
by: Jarkko Johansson, et al.
Published: (2023-01-01)

Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release
by: Pes, R, et al.
Published: (2016)

Evaluation of D1 and D2 dopamine receptor segregation in the developing striatum using BAC transgenic mice.
by: Dominic Thibault, et al.
Published: (2013-01-01)

Fyn Signaling Is Compartmentalized to Dopamine D1 Receptor Expressing Neurons in the Dorsal Medial Striatum
by: Khanhky Phamluong, et al.
Published: (2017-08-01)

Sub-second dopamine detection in human striatum.
by: Kenneth T Kishida, et al.
Published: (2011-01-01)

Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457.
by: Kenji Ishibashi, et al.
Published: (2011-01-01)

Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D<sub>3 </sub>receptor
by: Borwege Sabine, et al.
Published: (2004-10-01)

The dopamine D2 receptor gene in lamprey, its expression in the striatum and cellular effects of D2 receptor activation
by: Robertson, B, et al.
Published: (2012)

The dopamine D2 receptor gene in lamprey, its expression in the striatum and cellular effects of D2 receptor activation.
by: Brita Robertson, et al.
Published: (2012-01-01)

Calbindin-D28K limits dopamine release in ventral but not dorsal striatum by regulating Ca2+ availability and dopamine transporter function
by: Brimblecombe, K, et al.
Published: (2019)

Pramipexole has a neuroprotective effect in spinal cord injury and upregulates D2 receptor expression in the injured spinal cord tissue in rats
by: Xuchen Liu, et al.
Published: (2023-09-01)

Dopamine D2L Receptor Deficiency Alters Neuronal Excitability and Spine Formation in Mouse Striatum
by: Gubbi Govindaiah, et al.
Published: (2022-01-01)

Nicotine amplifies reward-related dopamine signals in striatum.
by: Rice, M, et al.
Published: (2004)

Dopamine Modulates the Processing of Food Odour in the Ventral Striatum
by: Olivier Rampin, et al.
Published: (2022-05-01)

Protein composition of axonal dopamine release sites in the striatum
by: Lauren Kershberg, et al.
Published: (2022-12-01)

Dopamine differentially modulates the size of projection neuron ensembles in the intact and dopamine-depleted striatum
by: Marta Maltese, et al.
Published: (2021-05-01)

Dopamine D<sub>4</sub> Receptor Is a Regulator of Morphine-Induced Plasticity in the Rat Dorsal Striatum
by: Alicia Rivera, et al.
Published: (2021-12-01)

Pramipexole use and the risk of pneumonia
by: Ernst Pierre, et al.
Published: (2012-09-01)

Inhibition of microRNA-200a Upregulates the Expression of Striatal Dopamine Receptor D2 to Repress Apoptosis of Striatum via the cAMP/PKA Signaling Pathway in Rats with Parkinson’s Disease
by: Dong-Mei Wu, et al.
Published: (2018-11-01)

Subthalamic nucleus exclusively evokes dopamine release in the tail of the striatum
by: Todd, KL, et al.
Published: (2022)

Dopamine release in human associative striatum during reversal learning
by: Filip Grill, et al.
Published: (2024-01-01)

A Feud that Wasn't: Acetylcholine Evokes Dopamine Release in the Striatum
by: Surmeier, D. James, et al.
Published: (2015)

Dopamine mediated dynamical changes in the striatum: a numerical study
by: Müller László, et al.
Published: (2009-07-01)

Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease
by: Masahiro Nomoto, et al.
Published: (2018-12-01)

Effect of Clarithromycin on the Pharmacokinetics of Cabergoline in Healthy Controls and in Patients With Parkinson’s Disease
by: Akiko Nakatsuka, et al.
Published: (2006-01-01)

Conservation of the Direct and Indirect Pathway Dichotomy in Mouse Caudal Striatum With Uneven Distribution of Dopamine Receptor D1- and D2-Expressing Neurons
by: Kumiko Ogata, et al.
Published: (2022-02-01)

Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum.
by: Subramaniam Jayanthi, et al.
Published: (2009-06-01)

Enhanced dopamine D1 and BDNF signaling in the adult dorsal striatum but not nucleus accumbens of prenatal cocaine treated mice
by: Thomas F. Tropea, et al.
Published: (2011-12-01)